warnings
WARNINGS Metaproterenol, like other beta adrenergic agonists, can produce a significant cardiovascular effect in some patients, as measured by pulse rate, blood pressure, symptoms, and/or ECG changes.
FDA label 0fc1a7e2-40f3-4d10-ad45-fa1404652b26
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 66eb4b4d-2388-49d3-8ffa-0b9bca75a28e
- SPL ID
- 0fc1a7e2-40f3-4d10-ad45-fa1404652b26
- Version
- 5
- Effective date
- 2016-11-07
- Source export date
- 2026-10-12
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:07:32
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 0fc1a7e2-40f3-4d10-ad45-fa1404652b26 | id | |
| spl set id | 66eb4b4d-2388-49d3-8ffa-0b9bca75a28e | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Adverse reactions are similar to those noted with other sympathomimetic agents. The following table of adverse experiences is derived from 44 clinical trials involving 1,120 patients treated with metaproterenol sulfate syrup: Metaproterenol Sulfate Syrup Incidence of Adverse Events Occurring in at least 1% of Patients Adverse Experience Incidence Number of Patients % Cardiovascular Tachycardia 68 6.1 Central Nervous System Headache 12 1.1 Nervousness 54 4.8 Gastrointestinal Nausea 15 1.3 Musculoskeletal Tremor 18 1.6
adverse reactions table
<table> <caption>Metaproterenol Sulfate Syrup Incidence of Adverse Events Occurring in at least 1% of Patients</caption> <col/> <col/> <col/> <tbody> <tr> <td> <content styleCode="bold">Adverse Experience</content> </td> <td> </td> <td> <content styleCode="bold">Incidence</content> </td> </tr> <tr> <td> </td> <td> Number of Patients </td> <td> <content styleCode="bold">%</content> </td> </tr> <tr> <td> <content styleCode="underline">Cardiovascular</content> </td> <td> </td> <td> </td> </tr> <tr> <td> Tachycardia </td> <td> 68 </td> <td> 6.1 </td> </tr> <tr> <td> <content styleCode="underline">Central Nervous System</content> </td> <td> </td> <td> </td> </tr> <tr> <td> Headache </td> <td> 12 </td> <td> 1.1 </td> </tr> <tr> <td> Nervousness </td> <td> 54 </td> <td> 4.8 </td> </tr> <tr> <td> <content styleCode="underline">Gastrointestinal</content> </td> <td> </td> <td> </td> </tr> <tr> <td> Nausea </td> <td> 15 </td> <td> 1.3 </td> </tr> <tr> <td> <content styleCode="underline">Musculoskeletal</content> </td> <td> </td> <td> </td> </tr> <tr> <td> Tremor </td> <td> 18 </td> <td> 1.6 </td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.